Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A > G melas mutation

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 3, 2008, Pages 349-

  Moriarty, K T ^a,c   McFarland, R ^b   Whittaker, R ^b   Burch, J ^a   Turnbull, H E ^b   Taylor, R W ^b   Turnbull, D M ^d  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c DARENT VALLEY HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; DROWSINESS; DRUG WITHDRAWAL; FEMALE; GENE MUTATION; HUMAN; MAGNESIUM BLOOD LEVEL; MELAS SYNDROME; OXYGEN SATURATION; PREECLAMPSIA; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; CESAREAN SECTION; DNA, MITOCHONDRIAL; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; GESTATIONAL AGE; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; MAGNESIUM SULFATE; MALE; MELAS SYNDROME; POINT MUTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RISK ASSESSMENT;

EID: 45749088976     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802048545     Document Type: Article

References (4)

1. Berkowitz K, Monteagudo A, Marks F et al. 1990. Mitochondrial myopathy and preeclampsia associated with pregnancy. American Journal of Obstetrics and Gynecology 162:146-147.
2. Brown DT, Herbert M, Lamb VK et al. 2006. Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet 368:87-89.
3. McFarland R, Taylor RW, Turnbull DM. 2007. Mitochondrial disease - its impact, etiology, and pathology. Current Topics in Developmental Biology 77:113-155.
4. Shoubridge EA, Wai T. 2007. Mitochondrial DNA and the mammalian oocyte. Current Topics in Developmental Biology 77:87-111.